Canaccord Genuity Starts Salix Pharmaceuticals (SLXP) at Buy
Tweet
Share
E-mailGet Alerts SLXP Hot Sheet
Price: $172.81 --0%
Rating Summary:
7 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 3 | New: 14
Rating Summary:
7 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 3 | New: 14
Join SI Premium – FREE
Canaccord Genuity initiated coverage on Salix Pharmaceuticals (NASDAQ: SLXP) with a Buy rating and a price target of $145.00.
For an analyst ratings summary and ratings history on Salix Pharmaceuticals click here. For more ratings news on Salix Pharmaceuticals click here.
Shares of Salix Pharmaceuticals closed at $123.97 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Upgrades Bajaj Finance Ltd. (BAF:IN) to Neutral
- UBS Starts Cipher Mining (CIFR) at Buy
- Jefferies Starts China Oilfield Services (2883:HK) (CHOLF) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
